Name: 4th Annual MarketsandMarkets Next-Gen Microbiome and Probiotics Conference
Start: 2022-06-16
End: 2022-06-17
Location: Double Tree by Hilton San Diego- Mission Valley

The ecology of human microbiome is known to be associated with both phenotype and environment. With the increasing focus on the development of human microbiome therapies and probiotics product &drug development various small innovative players are operating in the market.

However, inadequate research and regulatory policies in the human microbiome are some of the factors which restrain the progress. Learn about microbial innovation and applying the new microbiome findings along with the regulatory pathways for better therapeutic development. Also, witness discussions on Microbiome vs probiotics and the link between them.

Microbial Innovations- Applying new microbiome findings
Regulatory updates
Microbiome as a science and its clinical applications- skin, gut & women’s health
Pediatrics and infant health
Analyzing the concept of Probiotics
Strain Identification
R & D to commercialization- effectively translating research into commercialization
Right branding and marketing of probiotics products
The Future of Probiotics in the Consumer Marketplace

Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals from pharmaceuticals, nutraceuticals and therapeutics-based organizations from the departments of:

Microbiome discovery
Department of Biochemistry and Immunology
Microbiome science
Microbiology
Biological Science
Gut Biology
Human microbiome

CONFERENCE AGENDA

Registration	08:15 - 08:55
Welcome note from MarketsandMarkets	08:55 - 09:00
Opening remarks from the Chairman Julius Goepp, CEO, Evimero	09:00 - 09:05
Keynote Presentation: - A Taxonomy-Agnostic Approach to Targeted Microbiome Therapeutics Julius Goepp, CEO, Evimero	09:05 - 09:40
APPLYING NEW MICROBIOME FINDING & REGULATORY UPDATES
Species-level 16S Microbiome by Simultaneous, Weighted Analysis of Hypervariable Domains 1-8 Seth Crosby, Director, Research Collaborations, Washington University School of Medicine	09:40 - 10:15
Back to Health - An Evolutionary Biology Perspective on the Skin Microbiome Larry Weiss, CEO & Founder, Symbiome	10:15 - 10:50
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:50 - 11:35
Tissue and Circulating Microbiome - Application for oncology Sandrine Miller-Montgomery, Co-Founder, President and CEO, Micronoma	11:35 - 12:10
Panel Discussion- Updates in microbiome research and findings- Perspective from skin, gut and woman’s health expert	12:10 - 12:45
What the Heck is going on in Kid s Guts? Madeline Lauf, Founder, Begin Health	12:45 - 13:20
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:20 - 14:20
A robust in vivo microbiome testing protocol: testing the effect of microbiome products, with a quantitative readout to support with claims substantiation Oliver Worsley, Founder, Sequential Skin	14:20 - 14:55
ANALYZING THE CONCEPT OF PROBIOTICS
Host cell-receptor targeted bioengineered probiotics against enteric infection and IBD Arun Bhunia, Professor of Food Microbiology, Chair,, Purdue Institute of Inflammation, Immunology and Infectious Disease	14:55 - 15:30
Understanding Probiotic Cell Health Using Flow Cytometry Dana Buckman, CEO, BioForm Solutions	15:30 - 16:05
Afternoon Refreshments and Poster Presentation \| One-to-One Networking Meetings	16:05 - 16:45
The Evolution of Probiotics for Consumer Health Products Peter Leighton, CEO, ProSperity Bioscience	16:45 - 17:20
Closing remarks from the Chairman	17:25 - 17:30
Drinks Reception & Networking End of Day 1	17:25 - 17:25

Registration	08:15 - 08:55
Welcome note from MarketsandMarkets	08:55 - 09:00
Opening Remarks from the Chairman	09:00 - 09:05
EFFECTIVELY TRANSLATING MICROBIOME RESEARCH INTO PRODUCTS
Keynote Presentation: How to modulate the oral microbiome for systemic health Emily Stein, CEO, Primal Health Inc.	09:05 - 09:40
Multi-omic Systems Biology approach to improved diagnostics and therapeutics in chronic diseases, cancers, and aging Ryan Toma, Research Scientist, Viome	09:40 - 10:15
Monitoring the Skin Microbiome Nicole M. Scott, CEO and Founder, Cybele Microbiome	10:15 - 10:50
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:50 - 11:35
Precise Microbiome Editing to Change How We Treat Chronic Bacterial Diseases Yug Varma, CEO, Phi Therapeutics	11:35 - 12:10
Panel Discussion- Where is Microbiome Science today – Closer to Darwin, Newton, or Heisenberg	12:10 - 12:50
Live Probiotics – Topical application for the skin Maya Ivanjesku, Chief Scientific Officer, Dakota Biotech	12:50 - 13:10
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:10 - 13:10